Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Centre Oscar Lambret
Wake Forest University Health Sciences
The Netherlands Cancer Institute
Ocellaris Pharma, Inc.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Transgene
Shasqi, Inc.
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Young Adult Survivors United
Mayo Clinic
Eli Lilly and Company
Washington University School of Medicine
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
ADC Therapeutics S.A.
University of Kansas Medical Center
Hutchmed
University of Washington
Mayo Clinic
Elevation Oncology
IGM Biosciences, Inc.
Columbia University
Foghorn Therapeutics Inc.
Mayo Clinic
Rain Oncology Inc
Noxopharm Limited
C4 Therapeutics, Inc.
Pfizer
Immodulon Therapeutics Ltd
University of Maryland, Baltimore
Shanghai PerHum Therapeutics Co., Ltd.
Shanghai PerHum Therapeutics Co., Ltd.
Rain Oncology Inc
Sumitomo Pharma America, Inc.
NantCell, Inc.
Ludwig-Maximilians - University of Munich
Dana-Farber Cancer Institute
Washington University School of Medicine
Monopar Therapeutics
Fred Hutchinson Cancer Center
University of Virginia
Pfizer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Y-mAbs Therapeutics
Jonsson Comprehensive Cancer Center